104 related articles for article (PubMed ID: 3446541)
21. [Treatment of blepharospasm with botulinum toxin].
Pikielny RT; Micheli FE; Fernández Pardal MM; Casas Parera I; Giannaula RJ; Gatto M
Medicina (B Aires); 1990; 50(2):129-34. PubMed ID: 2101846
[TBL] [Abstract][Full Text] [Related]
22. Pathological changes in levator palpebrae superioris muscle treated with botulinum toxin in a case of carotico-cavernous fistula.
Adams GG; Dilly PN
Br J Ophthalmol; 1991 Mar; 75(3):181-4. PubMed ID: 2012790
[TBL] [Abstract][Full Text] [Related]
23. Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm.
Kalra HK; Magoon EH
Ophthalmic Surg; 1990 May; 21(5):335-8. PubMed ID: 2381655
[TBL] [Abstract][Full Text] [Related]
24. Successful management of three consecutive cases of recurrent corneal erosion with botulinum toxin injections.
Mackie IA
Eye (Lond); 2004 Jul; 18(7):734-7. PubMed ID: 14765101
[No Abstract] [Full Text] [Related]
25. [Botulinum toxin injection-treatment of upper lid retraction in thyroid eye disease].
Dintelmann T; Sold J; Grehn F
Ophthalmologe; 2005 Mar; 102(3):247-50. PubMed ID: 15322802
[TBL] [Abstract][Full Text] [Related]
26. The use of botulinum toxin type A for the treatment of facial spasm.
Serrano LA
Bol Asoc Med P R; 1993; 85(1-3):7-11. PubMed ID: 8060446
[TBL] [Abstract][Full Text] [Related]
27. GaAs laser treatment of bilateral eyelid ptosis due to complication of botulinum toxin type A injection.
Majlesi G
Photomed Laser Surg; 2008 Oct; 26(5):507-9. PubMed ID: 18922092
[TBL] [Abstract][Full Text] [Related]
28. Total transplantation of the superior rectus muscle for ptosis. A new surgical approach.
Singh D; Singh M
Trans Ophthalmol Soc U K (1962); 1978 Apr; 98(1):71-4. PubMed ID: 285515
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the efficacy and safety of botulinum toxin type A to induce temporary ptosis in dogs.
Bittencourt MK; de Vasconcellos JP; Bittencourt MD; Malagó R; Bacellar M
J Ocul Pharmacol Ther; 2013 May; 29(4):431-6. PubMed ID: 23323889
[TBL] [Abstract][Full Text] [Related]
30. Control of eyelid retraction associated with Graves' disease with botulinum A toxin.
Biglan AW
Ophthalmic Surg; 1994 Mar; 25(3):186-8. PubMed ID: 8196925
[TBL] [Abstract][Full Text] [Related]
31. [Hemifacial spasm treated with botulinum toxin].
Jedynak CP; Palfi S; Vidailhet M; Kullmann B
Rev Neurol (Paris); 1993; 149(3):202-6. PubMed ID: 8235213
[TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options.
Nestor MS; Han H; Gade A; Fischer D; Saban Y; Polselli R
J Cosmet Dermatol; 2021 Oct; 20(10):3133-3146. PubMed ID: 34378298
[TBL] [Abstract][Full Text] [Related]
33. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A.
Steinsapir KD; Groth MJ; Boxrud CA
Dermatol Surg; 2015 Jul; 41(7):833-40. PubMed ID: 26057409
[TBL] [Abstract][Full Text] [Related]
34. Acquired blepharoptosis secondary to essential blepharospasm.
Bodker FS; Olson JJ; Putterman AM
Ophthalmic Surg; 1993 Aug; 24(8):546-50. PubMed ID: 8233320
[TBL] [Abstract][Full Text] [Related]
35. Randomized clinical trial of botulinum toxin plus glyceryl trinitrate vs. botulinum toxin alone for medically resistant chronic anal fissure: overall poor healing rates.
Jones OM; Ramalingam T; Merrie A; Cunningham C; George BD; Mortensen NJ; Lindsey I
Dis Colon Rectum; 2006 Oct; 49(10):1574-80. PubMed ID: 16988850
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of efficacy and safety of botulinum toxin type A injection in patients requiring temporary tarsorrhaphy to improve corneal epithelial defects.
Kasaee A; Musavi MR; Tabatabaie SZ; Hashemian MN; Mohebbi S; Khodabandeh A; Rajabi MT
Int J Ophthalmol; 2010; 3(3):237-40. PubMed ID: 22553562
[TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin in the treatment of paralytic strabismus and essential blepharospasm.
Thomas R; Mathai A; Rajeev B; Sen S; Jacob P
Indian J Ophthalmol; 1993 Oct; 41(3):121-4. PubMed ID: 8125543
[TBL] [Abstract][Full Text] [Related]
38. [Persistent corneal defects treated with botulinum toxin-induced ptosis].
Vleming EN; Pérez-Rico C; Montes MA; Pareja J
Arch Soc Esp Oftalmol; 2007 Sep; 82(9):547-50. PubMed ID: 17846944
[TBL] [Abstract][Full Text] [Related]
39. Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1.
Bernardini FP; Skippen B; Croasdell B; Cerón Bohórquez JM; Murray G; Sayed K; Walker L; Hartstein ME;
Aesthet Surg J; 2023 Aug; 43(9):955-961. PubMed ID: 36943792
[TBL] [Abstract][Full Text] [Related]
40. The role of botulinum toxin in the management of sixth nerve palsy.
Fitzsimons R; Lee J; Elston J
Eye (Lond); 1989; 3 ( Pt 4)():391-400. PubMed ID: 2606212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
